Skip to main content
Erschienen in: Neuroradiology 1/2009

01.01.2009 | Functional Neuroradiology

Absolute choline concentration measured by quantitative proton MR spectroscopy correlates with cell density in meningioma

verfasst von: Qiang Yue, Yasushi Shibata, Tomonori Isobe, Izumi Anno, Hiraku Kawamura, Qi-Yong Gong, Akira Matsumura

Erschienen in: Neuroradiology | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Introduction

This study was aimed to investigate the relationship between quantitative proton magnetic resonance spectroscopy (1H-MRS) and pathological changes in meningioma.

Materials and methods

Twenty-two meningioma cases underwent single voxel 1H-MRS (point-resolved spectroscopy sequence, repetition time/echo time = 2,000 ms/68, 136, 272 ms). Absolute choline (Cho) concentration was calculated using tissue water as the internal reference and corrected according to intra-voxel cystic/necrotic parts. Pathological specimens were stained with MIB-1 antibody to measure cell density and proliferation index. Correlation analysis was performed between absolute Cho concentration and cell density and MIB-1 labeled proliferation index.

Results

Average Cho concentration of all meningiomas before correction was 2.95 ± 0.86 mmol/kg wet weight. It was increased to 3.23 ± 1.15 mmol/kg wet weight after correction. Average cell density of all meningiomas was 333 ± 119 cells/HPF, and average proliferation index was 2.93 ± 5.72%. A linear, positive correlation between cell density and Cho concentration was observed (r = 0.650, P = 0.001). After correction of Cho concentration, the correlation became more significant (r = 0.737, P < 0.001). However, no significant correlation between Cho concentration and proliferation index was found. There seemed to be a positive correlation trend after correction of Cho concentration but did not reach significant level.

Conclusion

Absolute Cho concentration, especially Cho concentration corrected according to intra-voxel cystic/necrotic parts, reflects cell density of meningioma.
Literatur
1.
Zurück zum Zitat Claus EB, Bondy ML, Schildkraut JM (2005) Epidemiology of intracranial meningioma. Neurosurgery 57:1088–1095PubMedCrossRef Claus EB, Bondy ML, Schildkraut JM (2005) Epidemiology of intracranial meningioma. Neurosurgery 57:1088–1095PubMedCrossRef
2.
Zurück zum Zitat Bondy M, Ligon BL (1996) Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol 29:197–205PubMedCrossRef Bondy M, Ligon BL (1996) Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol 29:197–205PubMedCrossRef
3.
Zurück zum Zitat Longstreth WT, Dennis LK, McGuire VM (1993) Epidemiology of intracranial meningioma. Cancer 72:639–648PubMedCrossRef Longstreth WT, Dennis LK, McGuire VM (1993) Epidemiology of intracranial meningioma. Cancer 72:639–648PubMedCrossRef
4.
Zurück zum Zitat Demir MK, Iplikcioglu AC, Dincer A (2006) Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas. Eur J Radiol 60:48–55PubMedCrossRef Demir MK, Iplikcioglu AC, Dincer A (2006) Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas. Eur J Radiol 60:48–55PubMedCrossRef
5.
Zurück zum Zitat Cho YD, Choi GH, Lee SP (2003) (1)H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors. Magn Reson Imaging 21:663–672PubMedCrossRef Cho YD, Choi GH, Lee SP (2003) (1)H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors. Magn Reson Imaging 21:663–672PubMedCrossRef
6.
Zurück zum Zitat Majós C, Alonso J, Aguilera C (2003) Utility of proton MR spectroscopy in the diagnosis of radiologically atypical intracranial meningiomas. Neuroradiology 45:129–136PubMed Majós C, Alonso J, Aguilera C (2003) Utility of proton MR spectroscopy in the diagnosis of radiologically atypical intracranial meningiomas. Neuroradiology 45:129–136PubMed
7.
Zurück zum Zitat Tamiya T, Kinoshita K, Ono Y (2000) Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas. Neuroradiology 42:333–338PubMedCrossRef Tamiya T, Kinoshita K, Ono Y (2000) Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas. Neuroradiology 42:333–338PubMedCrossRef
8.
Zurück zum Zitat Shimizu H, Kumabe T, Shirane R (2000) Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. Am J Neuroradiol 21:659–665PubMed Shimizu H, Kumabe T, Shirane R (2000) Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. Am J Neuroradiol 21:659–665PubMed
9.
Zurück zum Zitat Ganslandt O, Stadlbauer A, Fahlbusch R (2005) Proton magnetic resonance spectroscopic imaging integrated into image-guided surgery: correlation to standard magnetic resonance imaging and tumor cell density. Neurosurgery 56:291–298PubMedCrossRef Ganslandt O, Stadlbauer A, Fahlbusch R (2005) Proton magnetic resonance spectroscopic imaging integrated into image-guided surgery: correlation to standard magnetic resonance imaging and tumor cell density. Neurosurgery 56:291–298PubMedCrossRef
10.
Zurück zum Zitat Gupta RK, Cloughesy TF, Sinha U (2000) Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 50:215–226PubMedCrossRef Gupta RK, Cloughesy TF, Sinha U (2000) Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 50:215–226PubMedCrossRef
11.
Zurück zum Zitat Miller BL, Chang L, Booth R (1996) In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci 58:1929–1935PubMedCrossRef Miller BL, Chang L, Booth R (1996) In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci 58:1929–1935PubMedCrossRef
12.
Zurück zum Zitat Shino A, Nakasu S, Matsuda M (1999) Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. J Neurosurg 91:928–934PubMedCrossRef Shino A, Nakasu S, Matsuda M (1999) Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. J Neurosurg 91:928–934PubMedCrossRef
13.
Zurück zum Zitat Matsumura A, Isobe T, Anno I (2005) Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study. J Clin Neurosci 12:416–420PubMedCrossRef Matsumura A, Isobe T, Anno I (2005) Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study. J Clin Neurosci 12:416–420PubMedCrossRef
14.
Zurück zum Zitat Biernat W (2000) 2000 World Health Organization classification of tumors of the nervous system. Pol J Pathol 51:107–114PubMed Biernat W (2000) 2000 World Health Organization classification of tumors of the nervous system. Pol J Pathol 51:107–114PubMed
15.
Zurück zum Zitat Isobe T, Matsumura A, Anno I (2002) Quantification of cerebral metabolites in glioma patients with proton MR spectroscopy using T2 relaxation time correction. Magn Reson Imaging 20:343–349PubMedCrossRef Isobe T, Matsumura A, Anno I (2002) Quantification of cerebral metabolites in glioma patients with proton MR spectroscopy using T2 relaxation time correction. Magn Reson Imaging 20:343–349PubMedCrossRef
16.
Zurück zum Zitat Jansen JF, Backes WH, Nicolay K (2006) 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 240:318–332PubMedCrossRef Jansen JF, Backes WH, Nicolay K (2006) 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 240:318–332PubMedCrossRef
17.
Zurück zum Zitat Kiricuta IC, Simplaceanu V (1975) Tissue water content and nuclear magnetic resonance in normal and tumor tissues. Cancer Res 35:1164–1167PubMed Kiricuta IC, Simplaceanu V (1975) Tissue water content and nuclear magnetic resonance in normal and tumor tissues. Cancer Res 35:1164–1167PubMed
18.
Zurück zum Zitat Komiyama M, Yagura H, Baba M (1987) MR imaging: possibility of tissue characterization of brain tumors using T1 and T2 values. Am J Neuroradiol 8:65–70PubMed Komiyama M, Yagura H, Baba M (1987) MR imaging: possibility of tissue characterization of brain tumors using T1 and T2 values. Am J Neuroradiol 8:65–70PubMed
19.
Zurück zum Zitat Cameron IL, Ord VA, Fullerton GD (1984) Characterization of proton NMR relaxation times in normal and pathological tissues by correlation with other tissue parameters. Magn Reson Imaging 2:97–106PubMedCrossRef Cameron IL, Ord VA, Fullerton GD (1984) Characterization of proton NMR relaxation times in normal and pathological tissues by correlation with other tissue parameters. Magn Reson Imaging 2:97–106PubMedCrossRef
20.
Zurück zum Zitat Sijens PE, Oudkerk M (2002) 1H chemical shift imaging characterization of human brain tumor and edema. Eur Radiol 12:2056–2061PubMed Sijens PE, Oudkerk M (2002) 1H chemical shift imaging characterization of human brain tumor and edema. Eur Radiol 12:2056–2061PubMed
21.
Zurück zum Zitat Spagnoli MV, Goldberg HI, Grossman RI (1986) Intracranial meningiomas: high-field MR imaging. Radiology 161:369–375PubMed Spagnoli MV, Goldberg HI, Grossman RI (1986) Intracranial meningiomas: high-field MR imaging. Radiology 161:369–375PubMed
22.
Zurück zum Zitat Schober R, Himuro H, Wechsler W (1988) Cystic changes and vascular permeability in meningiomas. Clin Neuropathol 7:16–21PubMed Schober R, Himuro H, Wechsler W (1988) Cystic changes and vascular permeability in meningiomas. Clin Neuropathol 7:16–21PubMed
23.
Zurück zum Zitat Chen TY, Lai PH, Ho JT (2004) Magnetic resonance imaging and diffusion-weighted images of cystic meningioma: correlating with histopathology. Clin Imaging 28:10–19PubMedCrossRef Chen TY, Lai PH, Ho JT (2004) Magnetic resonance imaging and diffusion-weighted images of cystic meningioma: correlating with histopathology. Clin Imaging 28:10–19PubMedCrossRef
24.
Zurück zum Zitat Cerda-Nicolas M, Lopez-Gines C, Perez-Bacete M (2000) Histopathological and cytogenetic findings in benign, atypical and anaplastic human meningiomas: a study of 60 tumors. J Neurooncol 47:99–108PubMedCrossRef Cerda-Nicolas M, Lopez-Gines C, Perez-Bacete M (2000) Histopathological and cytogenetic findings in benign, atypical and anaplastic human meningiomas: a study of 60 tumors. J Neurooncol 47:99–108PubMedCrossRef
25.
Zurück zum Zitat Dietemann JL, Heldt N, Burguet JL (1982) CT findings in malignant meningiomas. Neuroradiology 23:207–209PubMedCrossRef Dietemann JL, Heldt N, Burguet JL (1982) CT findings in malignant meningiomas. Neuroradiology 23:207–209PubMedCrossRef
26.
Zurück zum Zitat Chen CY, Lirng JF, Chan WP (2004) Proton magnetic resonance spectroscopy-guided biopsy for cerebral glial tumors. J Formos Med Assoc 103:448–458PubMed Chen CY, Lirng JF, Chan WP (2004) Proton magnetic resonance spectroscopy-guided biopsy for cerebral glial tumors. J Formos Med Assoc 103:448–458PubMed
27.
Zurück zum Zitat Li BS, Wang H, Gonen O (2003) Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. Magn Reson Imaging 21:923–928PubMedCrossRef Li BS, Wang H, Gonen O (2003) Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. Magn Reson Imaging 21:923–928PubMedCrossRef
28.
Zurück zum Zitat Sternberg SS (eds) (1999) Diagnostic surgical pathology. Lippincott Williams & Wilkins, Philadelphia, pp 438–444 Sternberg SS (eds) (1999) Diagnostic surgical pathology. Lippincott Williams & Wilkins, Philadelphia, pp 438–444
30.
Zurück zum Zitat Nafe R, Herminghaus S, Raab P (2003) Preoperative proton-MR spectroscopy of gliomas–correlation with quantitative nuclear morphology in surgical specimen. J Neurooncol 63:233–245PubMedCrossRef Nafe R, Herminghaus S, Raab P (2003) Preoperative proton-MR spectroscopy of gliomas–correlation with quantitative nuclear morphology in surgical specimen. J Neurooncol 63:233–245PubMedCrossRef
31.
Zurück zum Zitat Modha A, Gutin PH (2005) Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 57:538–550PubMedCrossRef Modha A, Gutin PH (2005) Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 57:538–550PubMedCrossRef
Metadaten
Titel
Absolute choline concentration measured by quantitative proton MR spectroscopy correlates with cell density in meningioma
verfasst von
Qiang Yue
Yasushi Shibata
Tomonori Isobe
Izumi Anno
Hiraku Kawamura
Qi-Yong Gong
Akira Matsumura
Publikationsdatum
01.01.2009
Verlag
Springer-Verlag
Erschienen in
Neuroradiology / Ausgabe 1/2009
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-008-0461-z

Weitere Artikel der Ausgabe 1/2009

Neuroradiology 1/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.